舒利迭吸入治疗老年重度阻塞性肺疾病临床分析.docVIP

舒利迭吸入治疗老年重度阻塞性肺疾病临床分析 　　[摘要] 目的 研究评价舒利迭吸入治疗老年重度慢性阻塞性肺疾病对患者血气及肺功能的影响。 方法 回顾性分析80例在我院确诊并接受治疗的老年重度慢性阻塞性肺疾病患者，根据患者的治疗方式分为对照、实验两组，每组40例，两组均贯彻实施吸氧、解痉、平喘、抗感染等常规治疗，实验组在此基础上加用舒利迭吸入治疗，研究过程中对两组治疗有效率，及治疗前后血气、肺功能指标变化的差异施以比较，并用统计学处理。 结果 实验组治疗总有效率为92.5%，对照组的治疗总有效率为72.5%，两者相比可见实验组治疗效果明显优于对照组，差异有统计学意义（P0.05），两组治疗后各指标同组比较均明显改善（P0.05），但相比之下实验组的改善幅度显著优于对照组（P0.05）。 结论 采用舒利迭吸入治疗老年重度慢性阻塞性肺疾病疗效肯定，明显缓解临床症状，且能有效改善患者血气与肺功能指标，是治疗本病的一种有效方案，适合在临床推广应用。 　　[关键词] 舒利迭；老年重度慢性阻塞性肺疾病；血气指标；肺功能 　　[中图分类号] R563.9 [文献标识码] B [文章编号] 2095-0616（2015）19-106-03 　　[Abstract] Objective To study the effect of blood gas and pulmonary function of salmeterol fluticasone propionate aerosol inhalation treatment of senile severe obstructive pulmonary disease. Methods Retrospectively analyzed 80 patients with senile severe obstructive pulmonary disease， who were diagnosed and were received treatment in our hospital， were divided into control group and experimental group according to the patients’ treatments， with 40 cases in each group. To carry out and implement the routine treatment of oxygen inhalation， spasmolysis， antiasthmatic， and anti-infection and so on in the two groups， and based on which， the experimental group was treated with salmeterol fluticasone propionate aerosol inhalation. To compare the differences of the treatment effective rate， the index changes of blood gas and pulmonary function of pre and post treatment between the two groups during the course of studying， and to make statistical treatment. Results The treatment total effective rate in experimental group（92.5%） was obviously better than which in control group（72.5%）， the differences was statically significant（P0.05）， while which after treatment had obviously improved（P0.05）， but the improved amplitude in experimental group was obviously better than which in control group（P0.05）. Conclusion Salmeterol fluticasone propionate aerosol inhalation treatment of senile severe obstructive pulmonary disease has definite therapeutic effect， could obviou